Poland· PL-100013927
Chlorchinaldin VP
A chlorquinaldol product containing chlorquinaldolum, registered in Poland by Bausch Health Ireland Ltd..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Chlorquinaldolum
- Manufacturer
- Bausch Health Ireland Ltd.
- Country
- Poland (PL)
- ATC code
- R02AA11
- ATC class
- Chlorquinaldol
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990231713
- gtin05909990881253
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under R02AA11
Chlorquinaldol, as other registers publish it.
Authorised across Europe · EMA
The same active substance is authorised in 1 EEA country. Names it is sold under:
- Romania · Clorchinaldol Arena, Sapromed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6e1569f8-02f8-47f0-8c56-12b9c5055a36 GET /v1/drugs/6e1569f8-02f8-47f0-8c56-12b9c5055a36?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki do ssania",
"source": "urpl",
"strength": "2 mg",
"packaging": "05909990231713 ¦ OTC ¦ 58439\n20 tabl.\n05909990881253 ¦ OTC ¦ 67569\n40 tabl.",
"substance": "Chlorquinaldolum 2 mg",
"common_name": "Chlorquinaldolum",
"pl_product_id": "100013927",
"pozwolenie_nr": "02317",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about chlorquinaldol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.